2,6-diaminotoluene has been researched along with fluorouracil in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amzel, LM; Gabelli, SB; Kinzler, KW; Maheshwari, S; McRobb, FM; Miller, MS; Vogelstein, B | 1 |
Junker-Walker, U; Martus, HJ; Plappert-Helbig, U | 1 |
2 other study(ies) available for 2,6-diaminotoluene and fluorouracil
Article | Year |
---|---|
Identification of allosteric binding sites for PI3Kα oncogenic mutant specific inhibitor design.
Topics: Allosteric Site; Class I Phosphatidylinositol 3-Kinases; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Mutant Proteins; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Structure-Activity Relationship | 2017 |
Evaluation of methyl methanesulfonate, 2,6-diaminotoluene and 5-fluorouracil: Part of the Japanese center for the validation of alternative methods (JaCVAM) international validation study of the in vivo rat alkaline comet assay.
Topics: Animals; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Fluorouracil; Liver; Male; Methyl Methanesulfonate; Phenylenediamines; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Stomach | 2015 |